Table 1.
Group I (n = 15) | Group II (n = 12) | Group III (n = 13) | Group IV (n = 13) | Group V (n = 12) | |
Amylase (U/L) | 278 ± 44 | 1664 ± 234 | 974 ± 110 | 384 ± 40 | 851 ± 56 |
Oxidative stress | |||||
MDA (nmol/g) | 12.3 ± 0.4 | 28.3 ± 0.7 | 18.2 ± 0.4 | 16.4 ± 0.4 | 20.1 ± 0.5 |
SOD (U/g) | 395 ± 7 | 254 ± 6 | 345 ± 16 | 282 ± 8 | 300 ± 9 |
GSHPx (U/g) | 51.6 ± 2.0 | 30.8 ± 0.9 | 35.8 ± 1.5 | 48.4 ± 0.7 | 45.6 ± 1.4 |
Bacterial translocation | |||||
MLNs | 2 (13%) | 12 (100%) | 8 (62%) | 6 (46%) | 7 (58%) |
Pancreas | 2 (13%) | 12 (100%) | 7 (54%) | 3 (23%) | 6 (50%) |
Histopathologic score | 2 (1-3) | 18 (14.5-19) | 13 (12.5-15) | 6 (4.5-7.5) | 9.5(7-11.75) |
Mortality | 0/15 (0%) | 5/17 (29%) | 3/16 (19%) | 3/16 (19%) | 4/16 (25%) |
MDA: Malondialdehyde; SOD: Superoxide dismutase; GSHPx: Glutathione peroxidase; MLNs: Mesenteric lymph nodes.